DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies

被引：0
|
作者：
Diana Cervantes-Madrid
Yvonne Wettergren
Peter Falk
Kent Lundholm
Annika G. Asting
机构：
[1] University of Gothenburg,Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy
[2] Sahlgrenska University Hospital,Department of Surgery
来源：
BMC Cancer | / 17卷
关键词：
Cancer stem cells; CD133/Prominin1; colorectal cancer; copy number variations; DNA alterations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] DNA alterations in Cd133+and Cd133-tumour cells enriched from intra-operative human colon tumour biopsies
    Cervantes-Madrid, Diana
    Wettergren, Yvonne
    Falk, Peter
    Lundholm, Kent
    Asting, Annika G.
    BMC CANCER, 2017, 17
  • [2] Expression profiling of CD133+ and CD133- epithelial cells from human prostate
    Shepherd, Christopher J.
    Rizzo, Sian
    Ledaki, Ioanna
    Davies, Melissa
    Brewer, Daniel
    Attard, Gerhardt
    de Bono, Johann
    Hudson, David L.
    PROSTATE, 2008, 68 (09): : 1007 - 1024
  • [3] Differential characteristics of CD133+ and CD133- Jurkat cells
    Anbarlou, Azadeh
    Atashi, Amir
    Soleimani, Masoud
    AkhavanRahnama, Mahshid
    Bohloli, Mahbobeh
    Mossahebi-Mohammadi, Majid
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2015, 51 (06) : 556 - 561
  • [4] CD133+ and CD133- Cancer stem cells in glioblastoma
    Beier, D.
    Hau, P.
    Proescholdt, M.
    Lohmeier, A.
    Aigner, L.
    Brawanski, A.
    Bogdahn, U.
    Beier, C. P.
    NEURO-ONCOLOGY, 2006, 8 (04) : 317 - 317
  • [5] CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
    Shmelkov, Sergey V.
    Butler, Jason M.
    Hooper, Andrea T.
    Hormigo, Adilia
    Kushner, Jared
    Milde, Till
    St. Clair, Ryan
    Baljevic, Muhamed
    White, Ian
    Jin, David K.
    Chadburn, Amy
    Murphy, Andrew J.
    Valenzuela, David M.
    Gale, Nicholas W.
    Thurston, Gavin
    Yancopoulos, George D.
    D'Angelica, Michael
    Kemeny, Nancy
    Lyden, David
    Rafii, Shahin
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (06): : 2111 - 2120
  • [6] Hexokinase II in CD133+ and CD133- Hepatoma BEL-7402 Cells
    Gong, Lei
    Cui, Zhuqingqing
    Yu, Xin
    Wei, Yuhua
    Peng, Jirun
    Leng, Xisheng
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (02) : 377 - 381
  • [7] Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line
    Feng, Jian-Ming
    Miao, Ze-Hong
    Jiang, Yi
    Chen, Yi
    Li, Jia-Xin
    Tong, Lin-Jiang
    Zhang, Jin
    Huang, Yi-Ran
    Ding, Jian
    CANCER BIOLOGY & THERAPY, 2012, 13 (14) : 1396 - 1406
  • [8] Cell cycle analysis of the CD133+ and CD133- cells isolated from umbilical cord blood
    Grskovic, B
    Ruzicka, K
    Karimi, A
    Qujeq, D
    Müller, MM
    CLINICA CHIMICA ACTA, 2004, 343 (1-2) : 173 - 178
  • [9] Characterization of megakaryocytes progenitor cells differentiated from umbilical cord blood CD133+ and CD133- cells
    Goodarzi, A.
    Pour, M. Aghaeii
    Firozi, A.
    Pourfathaollah, A.
    Tabatabaeian, A.
    Vaeli, S.
    Niroomanesh, S.
    Ebtekar, M.
    Kheirandish, M.
    VOX SANGUINIS, 2006, 91 : 245 - 245
  • [10] Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia
    Blazek, Ed R.
    Foutch, Jennifer L.
    Maki, Guitta
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 1 - 5
12345